Fourth Quarter 2023 End of Period Subscribers of 3.8 million, including 67 thousand End of Period Clinical SubscribersRevenues of $206.0 millionGross margin of 60.6%; excluding the net impact of.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to.
Andrew Thomas emphasized the importance of removing commercial and regulatory impediments to speed the adoption of green hydrogen SANTA CLARITA, Calif., Feb. 27, 2024 NewHydrogen, Inc. , the.
SAN DIEGO, CA, Feb. 21, 2024 via NewMediaWire – Sigyn Therapeutics, Inc. , a development-stage medical technology company, announced today the filing of its Form 10-K annual report with the.
VANCOUVER, BC, Feb. 21, 2024 /CNW/ - NGEx Minerals Ltd. is pleased to report remaining drill results from hole DPDH010 and full results for holes DPDH011 and DPDH014 from the Lunahuasi Project.